What type of study is this?

This is a Experimental Study study.

September 19, 2025Open Access

Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy

View Full Paper

Ask AI

Bookmark

Authors

JRJudith ReinhardUniversity of Basel SLShuo LinFujian Medical University EMEleonora MainoUniversity of Basel

Discussion

Member takes

Implication

Gene therapy using laminin-linking proteins shows significant muscle histology improvements in LAMA2-related muscular dystrophy, suggesting novel treatment avenues.

Key Points

Dual AAV therapy improved muscle function and histology in a LAMA2 MD mouse model, showing strong treatment potential.
Therapeutic efficacy was achieved with lower vector doses using myotropic capsids, enhancing treatment viability in affected individuals.
Linker proteins were delivered using muscle-specific and ubiquitous promoters, resulting in significant phenotypic restoration when administered at various disease stages.
This mutation-independent strategy presents a promising, immune-tolerable approach for treating LAMA2-related muscular dystrophy with broad applicability.

Cite This Study

Reinhard et al. (2025) studied this question.

synapsesocial.com/papers/68d464e031b076d99fa63b74 https://doi.org/10.1101/2025.09.16.676550

View Full Paper

Ask AI

Bookmark

Implication

Gene therapy using laminin-linking proteins shows significant muscle histology improvements in LAMA2-related muscular dystrophy, suggesting novel treatment avenues.

Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy

Discussion

Member takes

Implication

Key Points

Cite This Study

Dual AAV gene therapy using laminin-linking proteins ameliorates muscle and nerve defects in LAMA2-related muscular dystrophy

Discussion

Member takes

Implication

Key Points

Cite This Study

Also Consider

Also Consider